Drug Testing Process


U.S. Open Championship Drug Testing Process:

Compliance with the drug testing program is a condition of entry to the Championship. Any player who refuses to participate in the testing process may be disqualified and subject to sanctions.

Drug testing at the U.S. Open will be administered in cooperation with the PGA TOUR’s Anti-Doping Program. Click here for the Program Manual.

  • The list of Prohibited Substances and Methods is contained in Section 5 of the Manual 
  • The Therapeutic Use Exemption (“TUE”) process is addressed in Section 6 of the Manual 

    TUE requests must be submitted to the PGA TOUR no later than five (5) days after having been notified that you have been accepted into sectional qualifying, or within ten (10) days of having received an exemption to play in the U.S.Open Championship.

Questions regarding the Anti-Doping Program Manual and TUE process should be directed to the Executive Director of the PGA TOUR’s Anti-Doping Program at (904) 280-2487.

General questions regarding the USGA’s Anti-Doping Policy can be directed to the USGA’s Anti-Doping Program Administrator at (908) 234-2300 x1178.

*For the avoidance of doubt, the application of this Policy is for all participants in the championship proper, regardless of whether or not you are a member of the PGA TOUR.

 

U.S. Women's Open Championship Drug Testing Process:

Compliance with the drug testing program is a condition of entry to the Championship. Any player who refuses to participate in the testing process may be disqualified and subject to sanctions.

Drug testing at the U.S. Women's Open will be administered in cooperation with the LPGA's Drug Testing Program Protocol. Click here for the Protocol.

  • The Program Description, Anti-Doping Protocol, Prohibited Substance List, and examples of Permitted Mediations List, Frequently Asked Questions document, and Therapeutic Use Exemption (TUE) Application and Procedures are all separately identified. All TUE requests should be submitted in accordance with the LPGA Procedures and submitted to the LPGA no later than five (5) days after having been notified that you have been accepted into sectional qualifying, or within ten (10) days of having received an exemption to play in the U.S. Women’s Open Championship.  

Questions regarding the Anti-Doping Protocol or TUE Process should be directed to the LPGA’s Senior Counsel at (386) 274-6284 or Josh.Kane@lpga.com. Questions regarding particular substances, including dietary supplements and vitamins should be addressed to the LPGA Drug Reference Hotline at 1-877-285-1436 or at drugtesting@lpga.com.

General questions regarding the USGA’s Anti-Doping Policy can be directed to the USGA’s Anti-Doping Program Administrator at (908) 234-2300 x1178.

*For the avoidance of doubt, the application of this Policy is for all participants in the championship proper, regardless of whether or not you are a member of the LPGA.

U.S. Amateur Championship and U.S. Women's Amateur Championship Drug Testing Process:

Compliance with the drug testing program is a condition of entry to the Championship. Any player who refuses to participate in the testing process may be disqualified and subject to sanctions.

Drug testing at the U.S. Amateur Championship and U.S. Women’s Amateur Championship will be administered in cooperation with the International Golf Federation’s (IGF) Anti Doping Program. The Program Manual can be found on www.internationalgolffederation.org . The information can also be found on the Drug Free Sport (DFS) website on www.drugfreesport.com.

  1. Once on the DFS website, click the REC icon in the upper right hand corner of the page
  2. Click on the USGA icon and log into the site using the password usgarec
  3. Click Drug Program Information
  4. Click on the IGF Anti-Doping Policy
  5. Click on the current list of Prohibited Substances and Methods (also found at www.wada-ama.org)
  6. Click here for the Therapeutic Use Exemption(TUE) form - do not use the form from the IGF Policy manual/website
  • A TUE request must be received by the USGA’s Medical Advisor no later than five (5) days after having been notified that you have been accepted into sectional qualifying, or within ten (days) of having received an exemption to play in the U.S. Amateur Championship or U.S. Women’s Amateur Championship. Submit the USGA’s TUE form and any related questions and documentation directly to the USGA Medical Advisor-Thomas G. Hospel, MD, MBG at thospel@yahoo.com –Specific questions about medications, substances, methods, dietary supplements or vitamins, or to obtain a TUE should be sent directly to Dr. Thomas Hospel at thospel@yahoo.com or by phone (614) 537-3000.

Questions about dietary supplements and banned substances may also be sent to the National Center for Drug Free Sport at www.drugfreesport.com by 1) following the steps outlined above for the DFS website or 2) sent to DFS by facsimile #816-285-5068 or 3) by calling the REC hotline #(877) 285-1434.

General questions regarding the USGA’s Anti-Doping Policy can be directed to the USGA’s Anti-Doping Program Administrator at (908) 234-2300 x1178.